Concord Biotech IPO Information: The IPO of Concord Biotech has been scheduled with a fixed date. It will be open in the market from August 4 to August 8, 2023. The company aims to raise approximately ₹1551 crores through the IPO. The allocation for different investor categories is as follows: 35% for retail investors (retail quota), 50% for qualified institutional buyers (QIBs), and 15% for high net worth individuals (HNIs).

Objects for the Issue

Concord Biotech IPO Review (Apply or Not)

Review – Brokerage Firm

Concord Biotech IPO Date & Price Band Details

IPO Opening Date: Aug 04, 2023
IPO Closing Date: Aug 08, 2023
IPO Size: ₹ 1551 Crores
Offer for Sale: ₹ 1551 Crores
Face Value: ₹ 1 Per Equity Share
IPO Price Band: ₹705 to ₹741 Per Share
IPO Listing on: BSE & NSE
Retail Quota: 35%
QIB Quota: 15%
 NII Quota: 50%
Employee Discount: ₹ 70 Per Share
DRHP Draft Prospectus:
RHP Draft Prospectus:
Anchor Investors List:

Concord Biotech IPO Lot Size

The Concord Biotech IPO minimum application for Retail investors is 20 shares with the amount of ₹14,820. And retail investors can apply Maximum 13 lots with total 260 shares for amount of ₹192,660.

And The Concord Biotech IPO minimum application for HNI investors is 280 shares with the amount of ₹2,07,480. HNI investors can apply Maximum 68 lots with total 1360 shares for amount of ₹10,07,760.

Application Lot Size Shares Amount
Retail Minimum 1 20 ₹ 14,820
Retail Maximum 13 260 ₹ 1,92,660
Small HNI Minimum 14 280 ₹ 2,07,480
Big HNI Minimum 68 3350 ₹ 10,07,760

Concord Biotech IPO Allotment and Listing Dates

The Concord Biotech IPO Last date for application is Aug 8. and The Concord Biotech IPO allotment will be settled on Aug 11 and the IPO listing on Aug 18.

Price Band Announcement: July 31, 2023
Anchor Investors Allotment: August 3, 2023
Anchor Investors Allotment: August 4, 2023
IPO Close Date: August 8, 2023
Basis of Allotment: Aug 11, 2023
Refunds: Aug 14, 2023
Credit to Demat Account: Aug 17, 2023
IPO Listing Date: Aug 18, 2023

Check here IPO subscription status and IPO allotment status on their separate pages.

Concord Biotech IPO about Form and ASBA

To apply for the Concord Biotech IPO, you have a couple of options. The first is to utilize the ASBA (Application Supported by Blocked Amount) facility through your bank account’s online portal. Simply log in to your online banking account, navigate to the “Invest” section, and select the Concord Biotech IPO to apply.

Alternatively, you can download the IPO forms directly from the websites of the NSE (National Stock Exchange) or BSE (Bombay Stock Exchange). Look for the Concord Biotech IPO forms on their respective platforms, download them, fill in the required information, and then submit the completed forms either at your bank or through your broker.

Choose the method that is most convenient for you to apply for the Concord Biotech IPO.

Concord Biotech past Financial Report

Company Financials (₹ in Crs)
Total Revenue Total Assets Profit After Tax (PAT)
31-Mar-23 630.75 1513.98 234.89
31-Mar-22 736.35 1312.8 174.93
31-Mar-21 888.48 1182.55 240.08

Concord Biotech Valuation Report

Earning Per Share (EPS): ₹22.9/-
P/E Ratio -
RoNW (Return on Net Worth): 20%
NAV - as on 31-03-23 ₹ 123

Find out IPO valuation details of Concord Biotech including Earnings Per Share (EPS), Price Earnings Ratio, Net Yield (RoNW) and Net Asset Value (NAV) details.

Peer Group

Company details

Company Promoters

Concord Biotech IPO Registrar

Link Intime India Private Limited
Contact No: +91 22 4918 6200
E-mail: concordbiotech.ipo@linkintime.co.in
Website: www.linkintime.co.in

Concord Biotech IPO Allotment Status Check

Concord Biotech IPO Allotment Status Check on Linkintime website allotment URL.

Concord Biotech IPO Lead Managers

Company Address

Concord Biotech Limited
1482-86,
Trasad Road Dholka,
Ahmedabad – 382225
Phone: 079-6813 8700
Email: complianceofficer@concordbiotech.com
Website: https://www.concordbiotech.com/

Concord Biotech IPO FAQs

What is the Concord Biotech IPO?

The Concord Biotech IPO is a main-board IPO. They plan to raise Rs 1551 crore through IPO. The issue price is between ₹705 and ₹741 per share. The IPO will be listed on the BSE and NSE.

When is the Concord Biotech IPO opening and closing?

The specific dates for the opening Aug 04, 2023 and closing Aug 08, 2023 of the Concord Biotech IPOs for Investors.

How can I apply for the Concord Biotech?

You can apply for the Concord Biotech IPO through the ASBA facility provided by your bank. Alternatively, you can download the IPO application forms from the websites of the NSE or BSE and submit them at your bank or through your broker. Or you can also apply through the UPIs.

What’s the Investors Portion of Concord Biotech?

The investor’s portion for Concord Biotech QIB is 50%, NII is 15%, and Retail is 35%.

What is the Concord Biotech IPO Size and Price Band?

Concord Biotech size is ₹1551 crores. And Price Band is ₹705 to ₹741.

What is the Minimum and Maximum Lot Size for Concord Biotech for retails?

For the minimum bid is 20 Shares with (20 x 741) ₹14,820 amount while the maximum bid is 260 shares with (260 x 741) ₹192,660.

What is the Minimum and Maximum Lot Size for Concord Biotech for HNIs?

For the minimum bid is 280 Shares with (280 x 741) ₹2,07,480 amount while the maximum bid is 1360 shares with (1360 x 741) ₹10,07,760.

What is the date for Concord Biotech IPO Allotment and Unblock Amount?

Concord Biotech IPO allotment date is Aug 11, 2023 and Unblock balance date is Aug 12, 2023.

What is the Listing Date of Concord Biotech?

Concord Biotech IPO listing date is Aug 18, 2023. The IPO will be listed on BSE and NSE.

Leave a Reply

Your email address will not be published. Required fields are marked *